Diana W. Shineman - Concepedia

Author

Diana W. Shineman

Alzheimer's Drug Discovery Foundation

Also Known As

D.W. Shineman, Diana Shineman, Diana W Shineman, Diana W. Shineman

Publications

Citations

H-Index

Concepts

All Affiliations

Alzheimer's Drug Discovery Foundation University of Pennsylvania National Institute on Aging Columbia University University of Florida

About

Diana W. Shineman is an author at Alzheimer's Drug Discovery Foundation specializing in medicine, alzheimer's disease, and neurology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	10	1.5K
2	Social Sciences	4	4	1.1K
3	Health Sciences	2	2	146
4	Biochemistry	2	2	176
5	Public Health	1	1	15

Diana W. Shineman

Publications

1.6K

Citations

H-Index

Page 1

	Year	Citations
Role for Akt3/Protein Kinase Bγ in Attainment of Normal Brain Size Rachael Easton, Han Cho, Kristin Roovers, Molecular and Cellular Biology Brain DevelopmentBrain ScienceMetabolic RemodelingNormal Organ SizeSynaptic Signaling	2005	547
Mechanism of Ca2+ Disruption in Alzheimer's Disease by Presenilin Regulation of InsP3 Receptor Channel Gating King‐Ho Cheung, Diana W. Shineman, Marioly Müller, Neuron Signal TransductionAlzheimer's DiseaseInsp3 Receptor ChannelNeurophysiologyPhysiology	2008	448
Modulation of Nuclear Factor-κB Activity by Indomethacin Influences Aβ Levels but Not Aβ Precursor Protein Metabolism in a Model of Alzheimer's Disease Syaun Sung, Hengxuan Yang, Kunihiro Uryu, American Journal Of Pathology Neurodegenerative DiseasesAlzheimer's DiseaseBiochemistryMedicineDegenerative Pathology	2004	153
Accelerating drug discovery for Alzheimer's disease: best practices for preclinical animal studies Diana W. Shineman, Guriqbal S. Basi, Jennifer L. Bizon, Alzheimer s Research & Therapy Preclinical TherapeuticsDrug TargetNeurochemical BiomarkersAd Animal ModelsLaboratory Animal Study	2011	130
Current evidence for the clinical use of long-chain polyunsaturated N-3 fatty acids to prevent age-related cognitive decline and Alzheimer's disease Penny A. Dacks, Diana W. Shineman, Howard Fillit The journal of nutrition health & aging Neurodegenerative DiseasesAlzheimer's DiseaseAgingOmega-3 Fatty AcidMedicine	2013	67
Overcoming obstacles to repurposing for neurodegenerative disease Diana W. Shineman, John Alam, Margaret Anderson, Annals of Clinical and Translational Neurology Social SciencesNeuroregenerationAlzheimer's DiseaseOrphan DrugNeurology	2014	59
Molecular Determinants of Heritable Vitamin E Deficiency Samantha Morley, Candace Panagabko, Diana W. Shineman, Biochemistry	2004	36
Thromboxane Receptor Activation Mediates Isoprostane-Induced Increases in Amyloid Pathology in Tg2576 Mice Diana W. Shineman, Bin Zhang, Susan N. Leight, Journal of Neuroscience	2008	33
Guidelines to improve animal study design and reproducibility for Alzheimer's disease and related dementias: For funders and researchers Heather M. Snyder, Diana W. Shineman, Lauren G. Friedman, Alzheimer s & Dementia	2016	26
Constitutively Active Akt Inhibits Trafficking of Amyloid Precursor Protein and Amyloid Precursor Protein Metabolites through Feedback Inhibition of Phosphoinositide 3-Kinase Diana W. Shineman, Aleksandra S. Dain, Minkyu L. Kim, Biochemistry Protein SecretionNeurochemical BiomarkersAmyloid Precursor ProteinInsulin SignalingFeedback Inhibition	2009	23

Page 1